Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of benfotiamine in patients with early Alzheimer's disease, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Benfotiamine (benfotiamine)

Snippet

Sponsor: Alzheimer's Disease Cooperative Study (ADCS) | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING